Methotrexate for the treatment of juvenile idiopathic arthritis: process to approval for JIA indication in Japan. - Wikidata - awgldk - TriplyDB

Methotrexate for the treatment of juvenile idiopathic arthritis: process to approval for JIA indication in Japan.

Methotrexate for the treatment of juvenile idiopathic arthritis: process to approval for JIA indication in Japan.

http://www.wikidata.org/entity/Q37089689

about

Influence of polymorphisms within the methotrexate pathway genes on the toxicity and efficacy of methotrexate in patients with juvenile idiopathic arthritis.

P2860

Q34580608-6DFE900D-3B5F-4A13-99E7-27B4FBD215DD

P2860

Methotrexate for the treatment of juvenile idiopathic arthritis: process to approval for JIA indication in Japan.

http://www.wikidata.org/entity/Q37089689

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 25 September 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Methotrexate for the treatment ...... l for JIA indication in Japan.

@en

Methotrexate for the treatment ...... l for JIA indication in Japan.

@nl

type

label

Methotrexate for the treatment ...... l for JIA indication in Japan.

@en

Methotrexate for the treatment ...... l for JIA indication in Japan.

@nl

prefLabel

Methotrexate for the treatment ...... l for JIA indication in Japan.

@en

Methotrexate for the treatment ...... l for JIA indication in Japan.

@nl

P1433

Q37089689-FE6BA26C-B238-4134-91BF-97738FA3A941

P1476

Q37089689-2B247226-B4CD-4B02-80B0-E87002C2E68A

P2093

Q37089689-1707D9BC-0902-4803-B3C9-FBD625C96B65

Q37089689-3D2BBAB2-AD83-402D-8B3A-F158821F7DDF

Q37089689-41449711-5A91-4517-9B9E-9095F60743D9

Q37089689-5682816F-659E-4122-8F65-7EC07D33AE26

Q37089689-5EF052E9-76C2-4475-B58C-AD07903CA443

Q37089689-66BBAA21-579A-4F05-812B-4F8CFEC85392

Q37089689-7DC3785B-1594-45C8-93CA-1AF05B44EFCB

Q37089689-B1021B29-FF01-415D-BBB1-7C94599314BF

Q37089689-CB0868B9-D4AA-45FF-A9E4-E838631E38AA

P2860

Q37089689-01C8F3CD-37BC-4578-A031-B8EDCFC53152

Q37089689-13CD57EC-B964-4A2D-92B2-3A4A99397CAC

Q37089689-345E389C-531C-4302-9956-26C33A002E54

Q37089689-4C2BAE37-31F1-4AB0-9533-C2BDA1696895

Q37089689-54C5DC77-2FC6-43D2-8D25-F143A580D02C

Q37089689-54FEB2D3-06F5-4CC3-96AF-29604911F85C

Q37089689-7BE2CC5A-5951-4542-B148-5506E44CC099

Q37089689-7E6AF303-4970-4E83-86B9-31EF614655D4

Q37089689-861A7FE2-6E95-40A9-ABF1-3EBF4B996081

Q37089689-C11B4EE3-DCC9-4B05-B07B-060084DFA363

P304

Q37089689-D4231686-BD53-4312-BBA7-25D4E6AA9542

P31

Q37089689-3B6A344F-6DB8-46EB-A034-17FBF957A932

Q37089689-5758E21D-8553-4808-A7F6-4FD985ECAD69

P356

Q37089689-228F1C3F-8A67-4917-8F62-8EB5D916B08B

P433

Q37089689-C1AF6F50-C8C5-460A-BAD2-0810B2B0960F

P478

Q37089689-ED2E0D5C-8820-46D0-97A2-C97863EDFCB1

P577

Q37089689-E74FCF0F-1CC5-4A0A-AB47-8E39D74D7859

P698

Q37089689-87D22FC9-6994-4719-BA8C-6D88C396A6D6

P921

Q37089689-912BC6D2-AB0A-4D90-9A59-F6CD349BF1C1

Q37089689-EC682E11-6F81-41F7-8CE5-AF4D6627BAC8

P932

Q37089689-F4B5A788-7720-4E99-9ADE-038F47C27B9E

P356

S10165-008-0123-3

P1433

Modern Rheumatology

P1476

Methotrexate for the treatment ...... l for JIA indication in Japan.

@en

P2093

Masaaki Mori

http://www.w3.org/2001/XMLSchema#string

Minako Tomiita

http://www.w3.org/2001/XMLSchema#string

Satoshi Fujikawa

http://www.w3.org/2001/XMLSchema#string

Shumpei Yokota

http://www.w3.org/2001/XMLSchema#string

Syuji Takei

http://www.w3.org/2001/XMLSchema#string

Takuji Murata

http://www.w3.org/2001/XMLSchema#string

Takuya Naruto

http://www.w3.org/2001/XMLSchema#string

Tomoyuki Imagawa

http://www.w3.org/2001/XMLSchema#string

Yasuhiko Itoh

http://www.w3.org/2001/XMLSchema#string

P2860

Randomized, placebo-controlled, crossover trial of low-dose oral methotrexate in children with extended oligoarticular or systemic arthritis.

Anti-interleukin 6 receptor antibody treatment in rheumatic disease.

Methotrexate for treating juvenile idiopathic arthritis.

Use of methotrexate in juvenile idiopathic arthritis.

Performance of the preliminary definition of improvement in juvenile chronic arthritis patients treated with methotrexate. Italian Pediatric Rheumatology Study Group

Hepatitis B vaccination in children with juvenile idiopathic arthritis.

The use of non-steroidal anti-inflammatory drugs in paediatric rheumatic diseases.

Comparative efficacy and safety of advanced drug therapy in children with juvenile rheumatoid arthritis.

[A survey of the doses of methotrexate and salazosulfapyridine in Japanese patients with rheumatoid arthritis]

Methotrexate in resistant juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind, placebo-controlled trial. The Pediatric Rheumatology Collaborative Study Group and The Cooperative Children's Study Group.

P304

1-11

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/S10165-008-0123-3

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P577

2008-09-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18815725

http://www.w3.org/2001/XMLSchema#string

P921

biomedical investigative technique

juvenile rheumatoid arthritis

P932

2638602

http://www.w3.org/2001/XMLSchema#string